Seres Therapeutics (1S90.F) Q1 2025 Earnings

Mar 13Confirmed
Q1 2025
-3.62
-2.97
-2.31
-1.66

Details

Expected EPS
-3.62156167135
Actual EPS
-1.658682
Surprise EPS
1.96
Surprise Percent
+54.2%

Description

⁨Seres Therapeutics⁩ (⁦1S90.F⁩) has reported earnings of ⁦-1.658682⁩ per share for ⁦Q1 2025⁩.

0 Comments

Share your thoughts